+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mycoplasma Testing Market by Product & Service, Technique, Application, End-User - Global Forecast 2025-2030- Product Image
Mycoplasma Testing Market by Product & Service, Technique, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Mycoplasma Testing Market by Product & Service, Technique, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674108
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mycoplasma Testing Market grew from USD 1.00 billion in 2023 to USD 1.08 billion in 2024. It is expected to continue growing at a CAGR of 8.29%, reaching USD 1.75 billion by 2030.

Mycoplasma testing encompasses the identification and detection of mycoplasmas, a group of bacteria lacking cell walls, notable for their role in contaminating cell cultures and causing various infections in humans and animals. This testing is crucial across pharmaceuticals, biotechnology, and research laboratories to ensure the purity and efficacy of products and research, as mycoplasma contamination can compromise experimental data and therapeutics. The market for mycoplasma testing is driven by increasing demands for biologics and biosimilars, stricter contamination control regulations, and advancements in testing technologies - such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA). Emerging opportunities lie in the adoption of faster, cost-effective diagnostic technologies, driven by heightened awareness and regulatory pressures. Companies should focus on expanding product offerings with rapid testing kits and automated systems to seize market share. However, challenges such as high costs of sophisticated testing methods, the complexity of detecting diverse mycoplasma species, and variations in regulatory frameworks across regions could impede market growth. Continuous investment in research to develop affordable, accurate, and robust testing techniques can help overcome these barriers. Innovation opportunities lie in integrating artificial intelligence for data analysis and real-time monitoring, which can improve accuracy and efficiency in mycoplasma detection. The market shows a trend towards collaboration with tech firms to enhance diagnostic tools and leverage emerging technologies like CRISPR for targeted detection. Companies focusing on regulatory compliance and partnerships with academic institutions for cutting-edge research can thrive. Thus, the mycoplasma testing market is poised for growth, albeit with obstacles that require strategic innovation and adaptation in product development and market expansion strategies.

Understanding Market Dynamics in the Mycoplasma Testing Market

The Mycoplasma Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of mycoplasma related diseases
    • Rising demand for quality control in biotechnology and pharmaceutical industry
    • Growing importance of mycoplasma testings in cell culture and vaccine production
  • Market Restraints
    • Expensive diagnostics technique and limited availability of technical experties
  • Market Opportunities
    • Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
    • Development of automation for high throughput testings and reducing manual errors
  • Market Challenges
    • Ensuring consistent performance of test among evolving mycoplasma strains

Exploring Porter’s Five Forces for the Mycoplasma Testing Market

Porter’s Five Forces framework further strengthens the insights of the Mycoplasma Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Mycoplasma Testing Market

External macro-environmental factors deeply influence the performance of the Mycoplasma Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Mycoplasma Testing Market

The Mycoplasma Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Mycoplasma Testing Market

The Mycoplasma Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Mycoplasma Testing Market

The Mycoplasma Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mycoplasma Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioFire Diagnostics, Inc., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genecopoeia, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Meridian Bioscience, Inc., Minerva Biolabs GmbH, MP Biomedicals, LLC, Mycoplasma Experience Limited, Nelson Laboratories Fairfield, Inc., Norgen Biotek Corporation, Promocell GmbH, Savyon Diagnostics, Takara Bio Inc., Thermo Fisher Scientific, Inc., and Wuxi AppTec.

Market Segmentation & Coverage

This research report categorizes the Mycoplasma Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product & Service
    • Assays, Kits, & Reagents
    • Instruments
      • DNA Sequencers
      • ELISA Readers
      • Fluorescent Microscopes
      • PCR Systems
    • Services
      • Certification & Validation Services
      • Consulting Services
      • Testing Services
  • Technique
    • Direct DNA Staining
    • Enzyme-Linked Immunosorbent Assay
    • Nucleic Acid Testing
    • Polymerase Chain Reaction
  • Application
    • Cell Line Testing
    • Drug Discovery & Development
    • Virus Testing
  • End-User
    • Academic & Research Institutes
    • Cell Banks & Laboratories
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of mycoplasma related diseases
5.1.1.2. Rising demand for quality control in biotechnology and pharmaceutical industry
5.1.1.3. Growing importance of mycoplasma testings in cell culture and vaccine production
5.1.2. Restraints
5.1.2.1. Expensive diagnostics technique and limited availability of technical experties
5.1.3. Opportunities
5.1.3.1. Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
5.1.3.2. Development of automation for high throughput testings and reducing manual errors
5.1.4. Challenges
5.1.4.1. Ensuring consistent performance of test among evolving mycoplasma strains
5.2. Market Segmentation Analysis
5.2.1. Usage of PCR techniques in mycoplasma testings for rapid and precise clinical results
5.2.2. Rising adoption of mycoplasma testings in pharmaceutical & biotechnology sectors for cell therapy development
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Mycoplasma Testing Market, by Product & Service
6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Instruments
6.3.1. DNA Sequencers
6.3.2. ELISA Readers
6.3.3. Fluorescent Microscopes
6.3.4. PCR Systems
6.4. Services
6.4.1. Certification & Validation Services
6.4.2. Consulting Services
6.4.3. Testing Services
7. Mycoplasma Testing Market, by Technique
7.1. Introduction
7.2. Direct DNA Staining
7.3. Enzyme-Linked Immunosorbent Assay
7.4. Nucleic Acid Testing
7.5. Polymerase Chain Reaction
8. Mycoplasma Testing Market, by Application
8.1. Introduction
8.2. Cell Line Testing
8.3. Drug Discovery & Development
8.4. Virus Testing
9. Mycoplasma Testing Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Cell Banks & Laboratories
9.4. Contract Research Organizations
9.5. Pharmaceutical & Biotechnology Companies
10. Americas Mycoplasma Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Mycoplasma Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Mycoplasma Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. AnaBioTec and bioMérieux revolutionize mycoplasma testing with advanced NAT technologies and comprehensive validation services
13.3.2. QIAGEN launches new QIAcuity digital PCR kits, enhancing accuracy and efficiency of safety testing solutions
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. MYCOPLASMA TESTING MARKET RESEARCH PROCESS
FIGURE 2. MYCOPLASMA TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MYCOPLASMA TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MYCOPLASMA TESTING MARKET DYNAMICS
TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DNA SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ELISA READERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY FLUORESCENT MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CERTIFICATION & VALIDATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DIRECT DNA STAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL LINE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY VIRUS TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL BANKS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 54. CANADA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 55. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. CANADA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 57. CANADA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. CHINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 86. CHINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 87. CHINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. CHINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 89. CHINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CHINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. INDIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 92. INDIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. INDIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. INDIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 95. INDIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. INDIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 107. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 142. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 161. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 162. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 167. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 195. ITALY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. ITALY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 198. ITALY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. POLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 219. POLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. POLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 221. POLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 222. POLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 225. QATAR MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. QATAR MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 227. QATAR MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 228. QATAR MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 251. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 252. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 270. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 285. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Mycoplasma Testing Market, which are profiled in this report, include:
  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, Inc.
  • Bionique Testing Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Bioarray
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Genecopoeia, Inc.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Minerva Biolabs GmbH
  • MP Biomedicals, LLC
  • Mycoplasma Experience Limited
  • Nelson Laboratories Fairfield, Inc.
  • Norgen Biotek Corporation
  • Promocell GmbH
  • Savyon Diagnostics
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Wuxi AppTec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.75 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Mycoplasma Testing Market Size, Share & Trends Analysis by Product (Instruments, Kits & Reagents), Technology (PCR, ELISA, Direct Assay, Microbial Culture), Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Mycoplasma Testing Market Size, Share & Trends Analysis by Product (Instruments, Kits & Reagents), Technology (PCR, ELISA, Direct Assay, Microbial Culture), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Mycoplasma Testing Global Market Report 2024 - Product Image

Mycoplasma Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Mycoplasma Testing - Global Strategic Business Report - Product Image

Mycoplasma Testing - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Mycoplasma Testing Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments and Services), By Technology, By Application, By End User, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Mycoplasma Testing Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments and Services), By Technology, By Application, By End User, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Mycoplasma Testing Market 2024-2028 - Product Image

Mycoplasma Testing Market 2024-2028

  • Report
  • 177 Pages
  • Global
From

About the Mycoplasma Test Market

The Mycoplasma Test market is a segment of the Infectious Disease Testing market. Mycoplasma testing is used to detect the presence of mycoplasma bacteria, which can cause a variety of diseases in humans and animals. Mycoplasma testing is used to diagnose and monitor the progression of mycoplasma infections, as well as to monitor the effectiveness of treatment. Mycoplasma testing is typically performed using a variety of methods, including culture, PCR, and serology. Mycoplasma testing is used in a variety of settings, including clinical laboratories, research laboratories, and veterinary laboratories. Mycoplasma testing is used to diagnose and monitor a variety of diseases, including pneumonia, bronchitis, and urinary tract infections. Some companies in the Mycoplasma Test market include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Becton Dickinson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.